Otrivin Menthol 0.1% Nasal Spray: Xylometazoline 0.1% plus Menthol

Go To

Woman menthol vapours

Reduces blocked nose and sinus pressure1–4

Otrivin Menthol 0.1% Nasal Spray provides effective relief of nasal congestion and sinus pressure,1- 4 with menthol adding a further sensation of improved airflow and freshness.

Woman smelling flowers

long-lasting relief of nasal congestion and sinus pressure

Otrivin Menthol 0.1% Nasal Spray is recommended for individuals who need long-lasting (lasts for up to 12 hours) relief from nasal congestion and sinus pressure.1-4

Fresh menthol leaves

Xylometazoline and Menthol: Unblocking with a cooling effect

Otrivin Menthol 0.1% Nasal Spray contains the active ingredient xylometazoline 0.1% plus menthol (preservative-free):

  • It eases nasal congestion in minutes by constricting dilated blood vessels in the nasal mucosa
  • It reduces symptoms of hypersecretio ns and facilitates sinus drainage
  • Menthol in the formulation provides a cooling effect and a sensation of breathing easier1-4

Recommend Otrivin Menthol 0.1% Nasal Spray to your patients for long-lasting relief from nasal congestion and sinus pressure

Otrivin Menthol 0.1% Nasal Spray

Otrivin Menthol 0.1% Nasal Spray (Xylometazoline hydrochloride 0.1% + menthol)

For patients who are looking for rapid and effective relief of nasal congestion and sinus pressure.1–4

Otrivin Menthol 0.1% Nasal Spray product details

  • Active ingredients:1

    Nasal spray solution (metered-dose spray):

    • Otrivin 0.1% nasal solutions contain 1 mg/mL of xylometazoline hydrochloride.

    Inactive ingredients:1

    • Menthol.

  • Always read the label prior use.

    Dosing instructions:1

    • For adults and children 12 years of age and over
    • 1 spray into each nostril up to 3-4 times daily, as needed
    • Do not exceed the recommendation dose.
    • It is recommended that the last application be made just before retiring to bed
    • Otrivin should not be used for more than 7 consecutive days

    How to use

    1. Do not cut the nozzle. The metered dose spray is ready to prime before use.
    2. Clear your nose.
    3. Remove protective cap.
    4. Before using for the first time, prime the pump by performing a few pumping motions until an even spray is released into the air. At subsequent applications the dosing spray pump will be ready for instant use. Be very careful not to spray in the eyes or mouth.
    5. Hold the bottle upright with thumb under base and nozzle between two fingers
    6. Lean forward slightly and insert the nozzle into the nostril.
    7. Spray and breathe in gently through the nose at the same time
    8. Repeat with the other nostril.
    9. Clean and dry the nozzle before replacing back the cap right after use.
    10. To avoid possible spread of infection, the spray should only be used by one person.
    • If you have any further questions on the use of this product, ask your doctor or pharmacist.

    • Xylometazoline, like other sympathomimet ic agents, should be used with caution in patients showing a strong reaction to adrenergic substances, as manifested by signs of insomnia, dizziness, tremors, cardiac arrhythmia, or elevated blood pressure
    • Otrivin Menthol 0.1% Nasal Spray should be used with caution in patients with hypertension, cardiovascular disease, hyperthyroidism , diabetes mellitus, phaeochromocy toma, prostatic hypertrophy, monoamine oxidase inhibitors (MAOI) treatment, or who have received them in the last two weeks
    • As with other topical vasoconstrictor s, it should not be used for more than 7 consecutive days; prolonged or excessive use may cause rebound congestion and/or atrophy of the nasal mucosa
    • Keep out of sight and reach of children

Otrivin Menthol 0.1% Nasal Spray: long-lasting relief of nasal congestion and sinus pressure 1-4

Otrivin logo

The Otrivin range

Find out how the Otrivin range can help your patients.

Find out more

Register now

Register Now

Join the Community

Register now

Patient care resources icon

Patient care resources

Download resources for your patients.

Find out more